المؤلفون: Meletios A. Dimopoulos, Cristina Gasparetto, Maeva Hellet, Pekka Anttila, Sandrine Macé, Marcelo Capra, Jian Y Yin, Matthew W Jenner, Eduardo Yanez Ruiz, Sara Bringhen, Vania Hungria, Vladimir I. Vorobyev, Rao Saleem, Craig E. Cole, Bruno Paiva, Michele Cavo, Ravi Vij

المساهمون: HUS Comprehensive Cancer Center, Hematologian yksikkö, Helsinki University Hospital Area, Meletios A Dimopoulo, Sara Bringhen, Pekka M Anttila, Marcelo Capra, Michele Cavo, Craig Emmitt Cole, Cristina Gasparetto, Vania Tietsche de Moraes Hungria, Matthew W Jenner, Vladimir I. Vorobyev, Eduardo Patricio Yanez Ruiz, Jian Y Yin, Rao Saleem, Maeva Hellet, Sandrine Macé, Bruno Paiva, Ravi Vij

المصدر: Blood

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Clinical Trials and Observations, Immunology, 3122 Cancers, Phases of clinical research, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Biochemistry, Gastroenterology, Dexamethasone, law.invention, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, isatuximab, dexamethasone, relapsed/refractory multiple myeloma, Randomized controlled trial, Refractory, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Adverse effect, Multiple myeloma, 030304 developmental biology, Aged, Isatuximab, Aged, 80 and over, 0303 health sciences, business.industry, Antibodies, Monoclonal, Cell Biology, Hematology, Middle Aged, medicine.disease, Progression-Free Survival, 3. Good health, Thalidomide, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Multiple Myeloma, medicine.drug

وصف الملف: ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b155c38aec5b28a10a6674ed65d2f0f
http://hdl.handle.net/10138/334769